How I Evaluate and Treat Peripheral Neuropathy in ATTR & AL Amyloidosis

Webinar Session: Wednesday, August 19th at 6 PM (ET) Zoom Meeting

(These sessions will not be recorded due to patient involvement and HIPAA laws)

To Register HERE

Learn how peripheral neuropathy is evaluated and treated in patients with amyloidosis, including TTR and AL types. This session reviews diagnostic approaches, symptom management, rehabilitation strategies, treatment options, and disease-modifying therapies that may help patients and care partners understand next steps, care planning, and support.

Amanda C. Peltier, MD, MS, is Professor of Neurology and Medicine and Chief of the Neuromuscular Division at Vanderbilt University Medical Center. Her work focuses on peripheral neuropathies, including amyloidosis-related peripheral and autonomic neuropathy. She is active in ATTR neuropathy guideline work and has contributed to identifying clinical trial endpoints for neuropathy.